Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

617
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
617
Pulmonary Function Tests01:25

Pulmonary Function Tests

980
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
980
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

618
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
618

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach.

Expert review of respiratory medicine·2023
Same author

Ultrasound-guided needle aspiration biopsy of isolated anterior mediastinal masses.

Pulmonology·2022
Same author

Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment.

ESMO open·2022
Same author

From pulmonary susceptible tuberculosis to extensively drug resistant tuberculosis: An interesting case report of a young Indian girl.

The Indian journal of tuberculosis·2020
Same author

Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Role of Stenotrophomonas maltophilia isolation in patients with non-CF bronchiectasis.

QJM : monthly journal of the Association of Physicians·2020

Related Experiment Video

Updated: Mar 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K

How we will diagnose IPF in the future.

L Richeldi1

  • 1From the Academic Unit of Clinical and Experimental Sciences NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK.

QJM : Monthly Journal of the Association of Physicians
|August 14, 2016
PubMed
Summary

Accurate diagnosis of idiopathic pulmonary fibrosis (IPF) is crucial for effective treatment. New genomic and imaging tools show promise in improving IPF diagnosis, especially for patients with atypical presentations or those unable to undergo biopsy.

More Related Videos

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
03:38

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K
Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
03:38

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

1.1K

Area of Science:

  • Pulmonology
  • Medical Diagnostics
  • Radiology

Background:

  • Idiopathic pulmonary fibrosis (IPF) diagnosis relies on clinical, laboratory, and imaging evaluations to exclude other causes.
  • High-resolution computed tomography (HRCT) is key for identifying patients needing surgical lung biopsy.
  • Current diagnostic methods face limitations, particularly with atypical HRCT findings or patient unsuitability for biopsy.

Purpose of the Study:

  • To explore novel diagnostic tools for idiopathic pulmonary fibrosis (IPF).
  • To address limitations in current IPF diagnostic approaches, especially for challenging cases.
  • To highlight advancements that may improve diagnostic accuracy and patient management.

Main Methods:

  • Review of standard diagnostic procedures for IPF, including HRCT and surgical lung biopsy.
  • Exploration of emerging technologies such as genomic techniques and molecular markers.
  • Consideration of new sampling methods like transbronchial cryobiopsies and advanced imaging (microCT).

Main Results:

  • New genomic and molecular tools are emerging to aid in IPF diagnosis.
  • Innovative imaging and biopsy techniques offer potential improvements.
  • These advancements aim to enhance the accuracy of IPF diagnosis and patient stratification.

Conclusions:

  • Advancements in genomic techniques and molecular markers are expected to improve IPF diagnostic accuracy.
  • Novel sampling procedures and imaging technologies will likely enhance diagnostic efforts and refine treatment strategies.
  • The integration of these new tools promises to improve patient outcomes in IPF management.